TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
ProboNova Medical Innovations AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
2
|
4
|
3 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-8
|
-1
|
0 |
| EBITDA |
-8
|
-1
|
0 |
| Total assets |
7
|
4
|
9 |
| Current assets |
7
|
4
|
9 |
| Current liabilities |
2
|
0
|
4 |
| Equity capital |
5
|
4
|
5 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
71.4%
|
100%
|
55.6% |
| Turnover per employee |
2
|
4
|
3 |
| Profit as a percentage of turnover |
-400%
|
-25.0%
|
0% |
| Return on assets (ROA) |
-114.3%
|
-25.0%
|
0% |
| Current ratio | 350.0% | 225.0% | |
| Return on equity (ROE) |
-160.0%
|
-25.0%
|
0% |
| Change turnover |
-3
|
2
|
-1 |
| Change turnover % |
-59%
|
81%
|
-18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.